The AKIKI 2 trial: a case for strategy of initiation instead of timing

Affiliations

Comment

Tukaram Ekanath Jamale. Lancet. 2021.

. 2021 Oct 2;398(10307):1215.

doi: 10.1016/S0140-6736(21)01858-4.

¹ Seth GS Medical College and King Edward Memorial Hospital, Mumbai 400012, India. Electronic address: tukaramjamale@yahoo.co.in.

No abstract available

Conflict of interest statement

I declare no competing interests.

The AKIKI 2 trial: a case for strategy of initiation instead of timing - Authors' reply.
Gaudry S, Hajage D, Louis G, Quenot JP, Dreyfuss D. Gaudry S, et al. Lancet. 2021 Oct 2;398(10307):1215-1216. doi: 10.1016/S0140-6736(21)01954-1. Lancet. 2021. PMID: 34600623 No abstract available.

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, Titeca-Beauport D, Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Bohé J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Rozec B, Cadoz C, Andreu P, Reignier J, Ricard JD, Quenot JP, Dreyfuss D. Gaudry S, et al. Lancet. 2021 Apr 3;397(10281):1293-1300. doi: 10.1016/S0140-6736(21)00350-0. Lancet. 2021. PMID: 33812488 Clinical Trial.